Christopher B. Prescott

James S. Richter

Mark J. Feldstein

Danielle A. Duszczyszyn

William P. Deni, Jr.

J. Brugh Lower

Emily Gabranski

Ryan McDonnell

C. Collette Corser

Justin Silverberg

Emma L. Capitanelli

Difgen Pharmaceuticals LLC

Aurinia Pharmaceuticals Inc

Last Docket Entry Date

Total Docket Entries

ANDA filing triggers Aurinia's patent defense for LUPKYNIS®, accusing a generic of infringing its `pharmacodynamic method` for `reducing the daily dosage` based on `eGFR`.

2:25-cv-03533 | Aurinia Pharma Inc v. Difgen Pharma LLC | Ex Parte

United States District of New Jersey

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5B
Mark J. Feldstein	L5A
Danielle A. Duszczyszyn	L5C
C. Collette Corser	L4A
Emily Gabranski	L4D
Ryan McDonnell	L3D
Emma L. Capitanelli	---- --
GibbonsLocal	L3C
William P. Deni, Jr.	L3E
J. Brugh Lower	L3E
Justin Silverberg	---- --

Name	Ratings
Midlige Richter	---- --
James S. Richter	L5E
Attorney at Law	---- --
Christopher B. Prescott	---- --